These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30923630)

  • 21. Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.
    Muniyappa R; Abel BS; Asthana A; Walter MF; Cochran EK; Remaley AT; Skarulis MC; Gorden P; Brown RJ
    J Clin Lipidol; 2017; 11(2):543-550. PubMed ID: 28502512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.
    Mosbah H; Vantyghem MC; Nobécourt E; Andreelli F; Archambeaud F; Bismuth E; Briet C; Cartigny M; Chevalier B; Donadille B; Daguenel A; Fichet M; Gautier JF; Janmaat S; Jéru I; Legagneur C; Leguier L; Maitre J; Mongeois E; Poitou C; Renard E; Reznik Y; Spiteri A; Travert F; Vergès B; Zammouri J; Vigouroux C; Vatier C
    Diabetes Obes Metab; 2022 Aug; 24(8):1565-1577. PubMed ID: 35445532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Therapeutic Options in Lipodystrophy.
    Akinci B; Meral R; Oral EA
    Curr Diab Rep; 2018 Oct; 18(12):139. PubMed ID: 30370487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.
    Pedicelli S; de Palma L; Pelosini C; Cappa M
    Ital J Pediatr; 2020 Oct; 46(1):158. PubMed ID: 33099310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy.
    Simha V
    Expert Rev Endocrinol Metab; 2014 May; 9(3):205-212. PubMed ID: 30736159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy.
    Cook K; Adamski K; Gomes A; Tuttle E; Kalden H; Cochran E; Brown RJ
    J Endocr Soc; 2021 Apr; 5(4):bvab019. PubMed ID: 33817539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
    Chan JL; Koda J; Heilig JS; Cochran EK; Gorden P; Oral EA; Brown RJ
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):137-49. PubMed ID: 26589105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.
    Meral R; Malandrino N; Walter M; Neidert AH; Muniyappa R; Oral EA; Brown RJ
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1739-e1751. PubMed ID: 34677608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of lipodystrophy: a step-by-step approach.
    Araújo-Vilar D; Santini F
    J Endocrinol Invest; 2019 Jan; 42(1):61-73. PubMed ID: 29704234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
    Brown RJ; Oral EA; Cochran E; Araújo-Vilar D; Savage DB; Long A; Fine G; Salinardi T; Gorden P
    Endocrine; 2018 Jun; 60(3):479-489. PubMed ID: 29644599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy.
    Simsir IY; Yurekli BS; Polat I; Saygili F; Akinci B
    Natl Med J India; 2020; 33(5):278-280. PubMed ID: 34213454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metreleptin: first global approval.
    Chou K; Perry CM
    Drugs; 2013 Jun; 73(9):989-97. PubMed ID: 23740412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.
    Christensen JD; Lungu AO; Cochran E; Collins MT; Gafni RI; Reynolds JC; Rother KI; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1493-500. PubMed ID: 25070319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.
    Shibata Y; Nakatsuka A; Eguchi J; Miyamoto S; Masuda Y; Awazawa M; Takaki A; Yoshida R; Yagi T; Wada J
    J Med Case Rep; 2018 Dec; 12(1):368. PubMed ID: 30545408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UNUSUAL PRESENTATIONS OF
    de Andrade NXS; Adiyaman SC; Yuksel BD; Ferrari CT; Eldin AJ; Saydam BO; Altay C; Sharma P; Bhave N; Little A; McKeever P; Onay H; Ozkal S; Secil M; Yenerel MN; Akinci B; Oral EA
    AACE Clin Case Rep; 2020; 6(2):e79-e85. PubMed ID: 32524016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication use.
    Adamski K; Cook K; Gupta D; Morris E; Tuttle E; Carr E; Cremasco F; Cochran E; Brown RJ
    Curr Med Res Opin; 2021 Nov; 37(11):1881-1889. PubMed ID: 34490811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.
    Patni N; Chard C; Araújo-Vilar D; Phillips H; Magee DA; Akinci B
    Orphanet J Rare Dis; 2024 Jul; 19(1):263. PubMed ID: 38992753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous Remission of Acquired Generalized Lipodystrophy Presenting in the Postpartum Period.
    Bhatia R; Chennupathi P; Rosenstein ED; Advani S
    JCEM Case Rep; 2024 Feb; 2(2):luae009. PubMed ID: 38314238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes.
    Jehl A; Cugnet-Anceau C; Vigouroux C; Legeay AL; Dalle S; Harou O; Marchand L; Lascols O; Caussy C; Thivolet C; Laville M; Disse E
    Diabetes Care; 2019 Oct; 42(10):2008-2010. PubMed ID: 31434650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.